NCT02750202View on ClinicalTrials.gov

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Genital Warts
Interventions
BIOLOGICAL

Quadrivalent HPV vaccine

Quadrivalent HPV vaccine doses administered intramuscular as 3 separate 0.5 ml doses at month 0, month 2 and month 6.

BIOLOGICAL

Hepatitis B vaccine

Hepatitis B vaccine doses administered intramuscular as 3 separate 0.5 ml doses at month 0, month 2 and month 6.

Trial Locations (2)

Unknown

Steve Biko Academic Hospital, Pretoria

Tygerberg Hospital, Cape Town

All Listed Sponsors
collaborator

University of Stellenbosch

OTHER

lead

University of Pretoria

OTHER